SNAP91 and central nervous system cancer: Expression of down-regulated DEGs SH3GL2 and SNAP91, which were found to be >2-fold lower in GBM samples by microarray analysis, was lower in malignant gliomas compared to non-tumor tissue and lower grade gliomas.